IM, N., HA, E., & AA, A. (2025). Design, synthesis, biological and computational evaluation of novel S/N-glycerolyl and peptide-conjugated [1,2,4]triazolo[1,5-a]pyrimidine derivatives as potent CDK2 inhibitors for anticancer therapy. Bioorganic chemistry, 165, 108952. https://doi.org/10.1016/j.bioorg.2025.108952
Chicago Style (17th ed.) CitationIM, Nagy, El-Sayed HA, and Abdel-Rahman AA. "Design, Synthesis, Biological and Computational Evaluation of Novel S/N-glycerolyl and Peptide-conjugated [1,2,4]triazolo[1,5-a]pyrimidine Derivatives as Potent CDK2 Inhibitors for Anticancer Therapy." Bioorganic Chemistry 165 (2025): 108952. https://doi.org/10.1016/j.bioorg.2025.108952.
MLA (9th ed.) CitationIM, Nagy, et al. "Design, Synthesis, Biological and Computational Evaluation of Novel S/N-glycerolyl and Peptide-conjugated [1,2,4]triazolo[1,5-a]pyrimidine Derivatives as Potent CDK2 Inhibitors for Anticancer Therapy." Bioorganic Chemistry, vol. 165, 2025, p. 108952, https://doi.org/10.1016/j.bioorg.2025.108952.